Acta Med. 2012, 55: 96-99
https://doi.org/10.14712/18059694.2015.63
Role of Electrophysiological Study and Catheter Ablation for Recurrent Ventricular Tachycardia Complicating Myocarditis
References
1. LT. Myocarditis. N Engl J Med 2009; 360: 1526–38.
<https://doi.org/10.1056/NEJMra0800028>
<PubMed>
2. JC, Hilliard AA, Cooper LT, Rihal CS. Diagnosis and Treatment of Viral Myocarditis. Mayo Clin Proc 2009; 84: 1001–9.
<https://doi.org/10.1016/S0025-6196(11)60670-8>
<PubMed>
3. JW, Dec GW. Myocarditis: Current Trends in Diagnosis and Treatment. Circulation 2006; 113: 876–90.
<https://doi.org/10.1161/CIRCULATIONAHA.105.584532>
4. G, Pankuwei S, Ritcher A, Schönian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID): first epidemiological results. Herz 2000; 25: 279–85.
<https://doi.org/10.1007/s000590050021>
5. M, Abraham WT, Casey DE, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transpalntation. Circulation 2009; 119: 1977–2016.
6. P, Scridon A. Ventricular arrhythmias complicating acute myocarditis. E-journal of the ESC Council for Cardiology Practice 2011; 9: 26.
7. RM, Vester EG, Brehm MU, et al. Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol 2000; 89: 24–35.
<https://doi.org/10.1007/s003920070080>
8. H, Yuwai K, Hiroe M. Guideline for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease from the Japanese Ministry of Health and Welfare (in Japanese). Japanese Ministry of Health and Welfare 1993; 6: 23–24.
9. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis and Granulomatous Disorders 2007; 27: 89–102.
10. G, Di Guardo G, Gulizia M, Lazzaro A, Regolo T. Fascicular Ventricular Tachycardia. Ital Heat J Suppl 2001; 2: 1181–6.
11. A. Idiophatic left ventricular tachycardia: assessment and treatment. Card Electrophysiol Rev 2002; 6: 448–57.
<https://doi.org/10.1023/A:1021100828459>
12. AE, Di Marco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350–e408.
13. DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Gudelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 746–837.
14. D, Surber R, Kuehnert H, Heinke M, Klein HU, Figulla HR. Succesfull use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction. Clin Res Cardiol 2010; 99: 129–31.
<https://doi.org/10.1007/s00392-009-0093-2>
15. TA, Sarlay R. Ventricular Fibrillation Associated With Use of Synephrine Containing Dietary Supplement. Mil Med 2009; 174: 1313–9.
<https://doi.org/10.7205/MILMED-D-01-5009>
